克洛法齐明:一种药物的旅程
Jiabin Xu1, Alexey Koval1, Vladimir L Katanaev2
1Translational Research Center in Oncohaematology, Department of Cell Physiology and Metabolism, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
|September 24, 2023
概括
最初用于结核病的克洛法齐明已被重新用于治疗麻风病,现在通过抑制Wnt信号通路,作为抗癌药物表现有前途. 这表明了药物重定向对新型癌症治疗的价值.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药物发现 药物发现 药物发现
- 在瘤学瘤学.
背景情况:
- 药物重新定位通过利用现有药物数据,为新药发现提供了更快,更安全的替代方案.
- 克洛法齐明是一种合成的riminophenazine,具有治疗性重新定位的历史,最初用于结核病,然后是麻风病和多药耐药结核病.
- 自20世纪90年代以来,新兴的研究强调了克洛法齐明在体外和体外的抗癌特性.
研究的目的:
- 为了探索克洛法齐明的抗癌潜力.
- 调查克洛法齐明在各种癌症中的有效性背后的机制.
- 突出克洛法齐明作为成功药物重定向的案例研究.
主要方法:
- 对克洛法齐明的药理性质和治疗应用的现有文献的审查.
- 在体外和体内研究的分析,调查克洛法齐明的抗癌作用.
- 检查拟议的作用机制,包括Wnt信号通路的抑制.
主要成果:
- 克洛法齐明对乳腺,结肠,肝脏和其他癌症具有抗癌作用.
- 一个关键的机制涉及克洛法齐明对致癌性Wnt信号通路的特定抑制.
- 克洛法西明的安全性和药理学概况从其以前的用途中得到了很好的证实.
结论:
- 克洛法齐明的重定向之旅是确定现有药物的新疗法应用的成功例证.
- 准Wnt信号通路是基于克洛法胺的癌症治疗的一个有前途的策略.
- 对克洛法齐明的进一步研究可能会为各种癌症提供新的治疗方法.
相关概念视频
Drug Elimination: Overview
1.7K
Drug elimination involves many complex processes and does not necessarily differentiate between distribution and elimination. It is divided into two primary components: excretion and biotransformation.
Excretion refers to removing a drug from the body, either in its unchanged form or as its metabolites. Nonvolatile and polar drugs are primarily excreted through the kidneys, with other pathways including bile, sweat, saliva, and milk. Volatile drugs such as anesthetic gases are excreted via the...
Excretion refers to removing a drug from the body, either in its unchanged form or as its metabolites. Nonvolatile and polar drugs are primarily excreted through the kidneys, with other pathways including bile, sweat, saliva, and milk. Volatile drugs such as anesthetic gases are excreted via the...
1.7K
Drug Administration and Therapy Phases: Overview
504
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
504
Drug Biotransformation: Overview
2.4K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.4K
Drug Elimination: Non-Renal Routes
2.4K
The liver plays a pivotal role in eliminating drugs and their metabolites, primarily through a process known as biliary excretion. This process involves the hepatocytes, the primary cells in the liver that generate bile. A range of transporters actively expels polar drugs or hydrophilic drug metabolites into the bile, which transports the drugs and metabolites into the small intestine. From here, they are eventually expelled from the body through feces. In some instances, the original drug or a...
2.4K
Drug Dosage Regimen: Overview
3.6K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.6K
Drug Elimination by Renal Route: Tubular Secretion
2.4K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.4K


